Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Recruiting1
Terminated2
Other2

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT07492316Phase 1Active Not Recruiting
RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Recurrent Medulloblastoma
PrincipalinvestigatorStart date: 2026-04-24
NCT04573140Phase 1Recruiting
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
StudychairStart date: 2021-12-13
NCT03334305Phase 1Terminated
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
High Grade GliomaMalignant Glioma
PrincipalinvestigatorStart date: 2018-08-27
NCT03396575Phase 1Terminated
Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)
Brain Stem GliomaDiffuse Intrinsic Pontine Glioma (DIPG)
PrincipalinvestigatorStart date: 2018-07-17
NCT07597070Phase 2Not Yet Recruiting
Universal Immunization to Fortify Immunotherapy Efficacy and Response
Stage 4 NSCLC
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Duane Mitchell, MD, PhD

University of Florida

Related
5 trials

Shared therapeutic areas:

Malignant GliomaHigh Grade Glioma

Worked with same sponsors:

Moffitt Clinical Research Network (MCRN)National Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Steven Lin, MD, PhD

M.D. Anderson Cancer Center

Related
1 trials

Shared therapeutic areas:

Stage 4 NSCLC

Worked with same sponsors:

M.D. Anderson Cancer CenterUniversity of Florida
Collaborated on 1 trial
Similarity Score14%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Brain Stem GliomaDiffuse Intrinsic Pontine GliomaHigh Grade Glioma
Similarity Score11%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaHigh Grade GliomaRecurrent Medulloblastoma
Similarity Score11%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Adult GlioblastomaMalignant Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Bilal Omer, MD

Baylor College of Medicine

Related
7 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaHigh Grade Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaHigh Grade Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Daniel Landi, MD

Duke University

Related
7 trials

Shared therapeutic areas:

Malignant GliomaRecurrent Medulloblastoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Glenn Lesser

Wake Forest University Health Sciences

Related
7 trials

Shared therapeutic areas:

Adult GlioblastomaMalignant Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Jan Drappatz, MD

Dana-Farber Cancer Institute

Related
1 trials

Shared therapeutic areas:

Malignant Glioma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT07492316Phase 1PrincipalInvestigator

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Recurrent Medulloblastoma
Active Not Recruiting
NCT04573140Phase 1StudyChair

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
Recruiting
NCT03334305Phase 1PrincipalInvestigator

Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas

High Grade GliomaMalignant Glioma
Terminated
NCT03396575Phase 1PrincipalInvestigator

Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)

Brain Stem GliomaDiffuse Intrinsic Pontine Glioma (DIPG)
Terminated
NCT07597070Phase 2PrincipalInvestigator

Universal Immunization to Fortify Immunotherapy Efficacy and Response

Stage 4 NSCLC
Not Yet Recruiting

All 5 trials loaded